Login to get immediate access to this content.
LoginSpeaker: Peter Schmid, UK
Abstract discussed:
- 181O - Interim analysis of atezolizumab + sacituzumab govitecan in TNBC: Watch the presentation from ESMO Breast 2024 now
The speakers and studies featured in this video series were selected independently by ESMO.
Published July 2024